BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4206080)

  • 1. Insulin and growth hormone secretion in rats with ventromedial hypothalamic lesions maintained on restricted food intake.
    Martin JM; Konijnendijk W; Bouman PR
    Diabetes; 1974 Mar; 23(3):203-8. PubMed ID: 4206080
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone and insulin levels in weanling rats with ventromedial hypothalamic lesions.
    Frohman LA; Bernardis LL
    Endocrinology; 1968 Jun; 82(6):1125-32. PubMed ID: 4869625
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin: hypothalamic inhibitor of the endocrine pancreas.
    Koerker DJ; Ruch W; Chideckel E; Palmer J; Goodner CJ; Ensinck J; Gale CC
    Science; 1974 Apr; 184(4135):482-4. PubMed ID: 4594711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of endocrine-metabolic changes in the weanling rat ventromedial syndrome.
    Bernardis LL; Goldman JK
    J Neurosci Res; 1976; 2(2):91-116. PubMed ID: 950680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone-releasing factor.
    Eikelboom R; Tannenbaum GS
    Endocrinology; 1983 Jan; 112(1):212-9. PubMed ID: 6128221
    [No Abstract]   [Full Text] [Related]  

  • 6. Integration of the secretory control mechanisms for insulin, glucagon, and growth hormone.
    Blackard WG; Andrews SS
    Curr Top Exp Endocrinol; 1974; 2():129-53. PubMed ID: 4597978
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.
    Tannenbaum GS
    Endocrinology; 1981 Jan; 108(1):76-82. PubMed ID: 6109623
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat.
    Harel Z; Tannenbaum GS
    Pediatr Res; 1995 Nov; 38(5):747-53. PubMed ID: 8552444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic compartmentalization of insulin. Evidence for pituitary control.
    Merimee TJ; Fineberg SE
    Diabetes; 1973 Jan; 22(1):25-9. PubMed ID: 4683793
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of insulin release and stimulation of growth hormone release by hypocalcemia in a boy.
    Laron Z; Rosenberg T
    Horm Metab Res; 1970 Mar; 2(2):121-2. PubMed ID: 5520907
    [No Abstract]   [Full Text] [Related]  

  • 11. Dependence of hypothalamic obesity on insulin, the pituitary and the adrenal gland.
    York DA; Bray GA
    Endocrinology; 1972 Apr; 90(4):885-94. PubMed ID: 4258778
    [No Abstract]   [Full Text] [Related]  

  • 12. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat.
    Rohner-Jeanrenaud F; Jeanrenaud B
    J Clin Invest; 1980 Apr; 65(4):902-10. PubMed ID: 6987269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of insulin release by perfused rat pancreases: effects of hypophysectomy, growth hormone, adrenocorticotropic hormone, and hydrocortisone.
    Curry DL; Bennett LL
    Endocrinology; 1973 Sep; 93(3):602-9. PubMed ID: 4352804
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lesion size in the ventromedial hypothalamus on growth hormone and insulin levels in weanling rats.
    Bernardis LL; Frohman LA
    Neuroendocrinology; 1970; 6(5):319-28. PubMed ID: 5482109
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of growth hormone on insulin secretion.
    Malaisse WJ; Malaisse-Lagae F; King S; Wright PH
    Am J Physiol; 1968 Aug; 215(2):423-8. PubMed ID: 4874761
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulsatile growth hormone secretion: suppression by hypothalamic ventromedial lesions and by long-acting somatostatin.
    Martin JB; Renaud LP; Brazeau P
    Science; 1974 Nov; 186(4163):538-40. PubMed ID: 4469678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy.
    Syvälahti E; Pynnönen S
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):285-8. PubMed ID: 320826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on insulin secretion and the pituitary insulin secretagogue beta-cell-tropin in the sand-rat (Psammomys obesus).
    Morton JL; Dunmore SJ; Beloff-Chain A; Adler JH
    Int J Obes; 1987; 11(1):9-18. PubMed ID: 3032819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia in tube-fed hypophysectomized rats bearing hypothalamic lesions.
    Han PW; Frohman LA
    Am J Physiol; 1970 Dec; 219(6):1632-6. PubMed ID: 4991955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.